5. Conclusion
The current study found that CSO might improve NAFLD via glycemic indices, inflammation, ME, and oxidant/antioxidant biomarkers modulation. CSO as one of the richest dietary sources of OM3FA can be recommended as a complementary therapy in NAFLD patients. Further trials are required to confirm the positive results of CSO in NAFLD patients.